AAAmro Alshareef

Amro Alshareef

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amro Alshareef has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Emulating the influence of exoskeleton stiffness on primary afferent feedback in rat isolated muscle–tendon unit

    by Amro A. Alshareef, Paul Nardelli, Surabhi N. Simha, Timothy C. Cope, Lena H. Ting, Gregory S. Sawicki

    Exoskeletons assist and augment movement, but their effects on proprioceptive feedback remain poorly understood because of challenges in making direct measures of sensory signals in humans. Here, we leveraged an animal model to explore how mechanical context akin to an elastic exoskeleton operating on a human lower limb joint influences primary muscle spindle firing. In an anesthetized rat preparation, we applied controlled stretches to the medial gastrocnemius with engineered springs (0–0.5 N mm−1) in parallel to the muscle–tendon unit (MTU) while modulating muscle activation to maintain overall system stiffness. Fascicle length was measured with sonomicrometry, force and MTU length with a servo motor, and spindle instantaneous firing rate (IFR) using dorsal root recordings. Trading off increases in exoskeleton stiffness with reductions in muscle activation decreased biological muscle force (3.1±0.6 N to 1.6±0.6 N, P<0.001) and stiffness (4.4±1.5 N mm−1 to 2.3±1.3 N mm−1, P<0.01), and increased fascicle length (7.9±1.3 mm to 8.3±1.5 mm, P<0.005). We found significant correlations between spindle firing and each independent fascicle dynamics factor we investigated (P<0.005). Thus, parallel stiffness modified muscle fascicle dynamics but did not alter spindle firing, possibly due to internal trade-offs in the salient fascicle dynamics that drive spindle behavior. Leveraging in situ experiments that enable monitoring of afferent feedback in complex mechanical contexts such as added parallel stiffness can provide a window into the effects of wearable devices on underlying sensory systems.


  • Open Access

    Influence of exoskeleton stiffness on primary afferent feedback during stretch perturbations of isolated muscle-tendon unit

    by Amro A. Alshareef, Paul Nardelli, Surabhi N. Simha, Timothy C. Cope, Lena H. Ting, Gregory S. Sawicki

    Exoskeletons assist and augment human movement, but their effects on proprioceptive feedback remain poorly understood. We examined how parallel exoskeleton stiffness influences primary muscle spindle firing. In an anesthetized rat preparation, controlled stretches of the medial gastrocnemius were applied with springs (0–0.5 N/mm) attached in parallel to the muscle-tendon unit (MTU) to simulate passive exoskeleton assistance. Fascicle length was measured with sonomicrometry, force and MTU length with a servo motor, and spindle instantaneous firing rate (IFR) with dorsal root recordings. Increasing exoskeleton stiffness decreased biological muscle force (3.1 ± 0.6 N to 1.6 ± 0.6 N, p < 0.001) and stiffness (4.4 ± 1.5 N/mm to 2.3 ± 1.3 N/mm, p < 0.01), while fascicle length increased (7.9 ± 1.3 mm to 8.3 ± 1.5 mm, p < 0.005). Despite these altered mechanics, spindle firing did not significantly change, and showed weak correlations with muscle length, velocity, force, and yank (R 2 ≤ 0.14). These results indicate that exoskeleton stiffness modifies fascicle dynamics without altering spindle firing. Previously proposed models of primary afferent firing did not sufficiently explain these results. This is the first in situ investigation of exoskeleton effects on primary afferent feedback during active contractions.

  • Open Access

    Gastrointestinal neuroprosthesis for motility and metabolic neuromodulation

    by Shriya Srinivasan, Marc-Joseph Antonini, Amro Alshareef, Atharva Sahasrabudhe, Josh Jenkins, Keiko Ishida, Johannes Kuosmanen, Alison Hayward, Seokkee Min, Robert Langer, et al.

    Gastrointestinal (GI) dysmotility and associated conditions affect over 20% of population, yet pharmacological, behavioural, and surgical interventions offer limited therapeutic efficacy. Targeted electrical stimulation addressing underlying neuromuscular pathology stands to transform our ability to treat dysmotility. Here, we developed a closed-loop GI neuroprosthesis which activates or relaxes GI tract musculature through electrochemical stimulation in response to sensed food stimuli. We additionally describe a tool supporting minimally invasive endoscopically guided implantation that can penetrate the mucosa, accurately localize the submucosa, and safely deploy this device to directly interface with the enteric nervous system. The neuroprosthesis enables generation of coordinated peristaltic waves, significantly increasing the motility rate in a swine model of oesophageal and stomach dysmotility (p < 0.05, student's t-test). Further, by directly modulating the myenteric plexus and thus mimicking meal ingestion, we induce peristalsis in a fasted state and achieve a metabolic response commensurate with a fed or satiated state. This neuroprosthesis and implantation platform expand opportunities in fundamental studies and treatments of metabolic and neuromuscular pathologies affecting the GI tract.


  • An ingestible self-propelling device for intestinal reanimation

    by Shriya S. Srinivasan, Julien Dosso, Hen-Wei Huang, George Selsing, Amro Alshareef, Johannes Kuosmanen, Keiko Ishida, Joshua Jenkins, Wiam Abdalla Mohammed Madani, Alison Hayward, et al.

    Postoperative ileus (POI) is the leading cause of prolonged hospital stay after abdominal surgery and is characterized by a functional paralysis of the digestive tract, leading to symptoms such as constipation, vomiting, and functional obstruction. Current treatments are mainly supportive and inefficacious and yield acute side effects. Although electrical stimulation studies have demonstrated encouraging pacing and entraining of the intestinal slow waves, no devices exist today to enable targeted intestinal reanimation. Here, we developed an ingestible self-propelling device for intestinal reanimation (INSPIRE) capable of restoring peristalsis through luminal electrical stimulation. Optimizing mechanical, material, and electrical design parameters, we validated optimal deployment, intestinal electrical luminal contact, self-propelling capability, safety, and degradation of the device in ex vivo and in vivo swine models. We compared the INSPIRE’s effect on motility in models of normal and depressed motility and chemically induced ileus. Intestinal contraction improved by 44% in anesthetized animals and up to 140% in chemically induced ileus cases. In addition, passage time decreased from, on average, 8.6 days in controls to 2.5 days with the INSPIRE device, demonstrating significant improvement in motility. Luminal electrical stimulation of the intestine via the INSPIRE efficaciously restored peristaltic activity. This noninvasive option offers a promising solution for the treatment of ileus and other motility disorders.


  • Open Access

    A vibrating ingestible bioelectronic stimulator modulates gastric stretch receptors for illusory satiety

    by Shriya S Srinivasan, Amro Alshareef, Alexandria Hwang, Ceara Byrne, Johannes Kuosmanen, Keiko Ishida, Joshua Jenkins, Sabrina Liu, Wiam Abdalla Mohammed Madani, Alison M Hayward, et al.

    Effective therapies for obesity require invasive surgical and endoscopic interventions or high patient adherence, making it challenging for patients with obesity to effectively manage their disease. Gastric mechanoreceptors sense distension of the stomach and perform volume-dependent vagal signaling to initiate the gastric phase and influence satiety. In this study, we developed a new luminal stimulation modality to specifically activate these gastric stretch receptors to elicit a vagal afferent response commensurate with mechanical distension. We designed the Vibrating Ingestible BioElectronic Stimulator (VIBES) pill, an ingestible device that performs luminal vibratory stimulation to activate mechanoreceptors and stroke mucosal receptors, which induces serotonin release and yields a hormonal metabolic response commensurate with a fed state. We evaluated VIBES across 108 meals in swine which consistently led to diminished food intake (~40%,P< 0.0001) and minimized the weight gain rate (P< 0.05) as compared to untreated controls. Application of mechanoreceptor biology could transform our capacity to help patients suffering from nutritional disorders.


  • Open Access

    A Vibrating Ingestible BioElectronic Stimulator Modulates Gastric Stretch Receptors for Illusory Satiety

    by Shriya S. Srinivasan, Amro Alshareef, Alexandria Hwang, Ceara Bryne, Johannes Kuosmann, Keiko Ishida, Joshua Jenkins, Sabrina Liu, Wiam Abdalla Mohammed Madani, Alison M Hayward, et al.

    Effective therapies for obesity either require invasive surgical or endoscopic interventions or high patient adherence, making it challenging for the nearly 42% of American adults who suffer from obesity to effectively manage their disease. Gastric mechanoreceptors sense distension of the stomach and perform volume-dependent vagal signaling to initiate the gastric phase and influence satiety. In this study, we developed a new luminal stimulation modality to specifically activate these gastric stretch receptors to elicit a vagal afferent response commensurate with mechanical distension. Here we developed the Vibrating Ingestible BioElectronic Stimulator (VIBES) pill - an ingestible device that performs luminal vibratory stimulation to activate mechanoreceptors and stroke mucosal receptors, which induces serotonin release as well as yields a hormonal metabolic response commensurate with a fed state. We evaluated VIBES across 108 meals in swine which consistently led to diminished food intake (∼40%, p< 0.0001) and minimized the weight gain rate (p< 0.03) as compared to untreated controls. Application of mechanoreceptor biology could transform our capacity to help patients suffering from nutritional disorders.


  • RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract

    by Shriya S. Srinivasan, Amro Alshareef, Alexandria V. Hwang, Ziliang Kang, Johannes Kuosmanen, Keiko Ishida, Joshua Jenkins, Sabrina Liu, Wiam Abdalla Mohammed Madani, Jochen Lennerz, et al.

    Oral drug delivery of proteins is limited by the degradative environment of the gastrointestinal tract and poor absorption, requiring parenteral administration of these drugs. Luminal mucus represents the initial steric and dynamic barrier to absorption. To overcome this barrier, we report the development of the RoboCap, an orally ingestible, robotic drug delivery capsule that locally clears the mucus layer, enhances luminal mixing, and topically deposits the drug payload in the small intestine to enhance drug absorption. RoboCap’s mucus-clearing and churning movements are facilitated by an internal motor and by surface features that interact with small intestinal plicae circulares, villi, and mucus. Vancomycin (1.4 kilodaltons of glycopeptide) and insulin (5.8 kilodaltons of peptide) delivery mediated by RoboCap resulted in enhanced bioavailability 20- to 40-fold greater in ex vivo and in vivo swine models when compared with standard oral delivery ( P < 0.05). Further, insulin delivery via the RoboCap resulted in therapeutic hypoglycemia, supporting its potential to facilitate oral delivery of drugs that are normally precluded by absorption limitations.